COVID-19 / Coronavirus
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021
2021-06-07 10:10
6013
* KN046 combined with platinum doublet chemotherapy is tolerated and has shown promising clinical benefit as IL treatment for stage IV NSCLC. * OS rate at 12 months and 15 months were both 74.9%; Similar survival was observed in patients with PD-L1≥1% and PD-L1<1%; * the median progression-f...
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021
2021-06-07 09:53
5574
* As of January 15, 2021, 9 patients were included in the efficacy analysis and 17 patients in the safety analysis. ORR was 55.6%, and DCR was 88.9%. * The updated results from this Phase II study will be presented at an upcoming medical meeting. A phase III clinical study of KN046 in combinat...
Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™, phase III results at ASCO 2021
2021-06-05 20:00
2945
SEOUL, South Korea, June 5, 2021 /PRNewswire/ -- Samsung Pharm Co., Ltd. announced today that the company presented the results of a phase III clinical trial of its pancreatic cancer immunotherapeutic drug candidate called 'RIAVAX™ (GV1001)' conducted in Korea at the 2021 American Society of Clin...
Singapore/ US based TurtleTree ready to commercialize Human Lactoferrin as first major product
2021-06-05 01:32
3463
SINGAPORE, June 5, 2021 /PRNewswire/ -- TurtleTree, the pioneer of cell-based milk, is now preparing for the launch of its first commercially scalable product. Human Lactoferrin lately also referred to as pink gold because of it's amazing properties for boosting immunity, resistance to infections...
Second Global Health Forum of Boao Forum for Asia Deepens Understanding of Universal Health and Global Cooperation
2021-06-04 20:03
3081
QINGDAO, China, June 4, 2021 /PRNewswire/ -- The Boao Forum for Asia (BFA) hosts the second Global Health Forum (The Forum) inQingdao. With rising consensus in the health field in the context of the pandemic, the Forum, with the aim of achieving the shared vision of "Health for All", saw partners...
Oxygen Concentrators have arrived, 135 oxygen concentrators donated by Fosun and its friendly enterprises arrive in Mumbai
2021-06-04 16:48
2137
HONG KONG, June 4, 2021 /PRNewswire/ -- On 1 June 2021, 135 oxygen concentrators, 5 ventilators, and 3,300 KN95 masks donated by Fosun Foundation ( Shanghai) (hereinafter referred to as "Fosun Foundation") and its friendly enterprises arrived inMumbai. This is the largest batch of oxygen concentra...
Prixa Closes US$3 million in Additional Funding to Enhance Accessibility and Digital Transformation of Indonesian Healthcare Services
2021-06-04 11:13
2352
* Funding led by MDI Ventures (MDI) and the Trans-Pacific Technology Fund (TPTF) with participation from existing investors including Siloam Hospitals Group. * This strategic investment will allow Prixa to expand its digital healthcare platform and user base. * Prixa is a leading health-tec...
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021
2021-06-04 02:14
2161
* Lunit to present four abstracts including one in a 'Poster Discussion Session' * AI-based tissue analysis platform 'Lunit SCOPE' to be launched within the second half of 2021: "We aim to make our AI the new standard for cancer treatment" SEOUL, Korea, June 3, 2021 /PRNewswire/ -- A new find...
iXensor Launches CE-marked Fully Digitized PixoTest COVID-19 Rapid Test with Digital Health Pass to Facilitate Safe Reopening of Economies
2021-06-03 17:00
1939
* A computer vision empowered rapid antigen test to avoid human errors. * An end-to-end digitized screening solution delivers test-to-report time in around 15 minutes. * The enterprise SaaS solution enables organizations to reopen with confidence. TAIPEI, June 3, 2021 /PRNewswire/ -- iXens...
Cell Care Joins the Generate Life Sciences Family to Create a Global Platform
2021-06-03 06:00
1930
The acquisition provides the companies with shared scientific knowledge and resources leading to a stronger foundation for advancing newborn stem cell banking and research MELBOURNE, Australia, June 3, 2021 /PRNewswire/ -- Cell Care, Australia's leading cord blood bank, today announced it has be...
Shanghai Asclepius Meditec and International Department of Central Committee of CPC Collaborate to Provide Emergency Support to Fight COVID-19 in Nepal
2021-06-02 20:00
1378
SHANGHAI, June 2, 2021 /PRNewswire/ -- The President of Asclepius Meditec – the
company behind the innovativeHydrogen Oxygen Generator with Nebulizer
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025
2021-06-02 18:03
1214
SANTA CLARA, Calif., June 2, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis on theglobal femtech solutions industry finds that the COVID-19 pandemic has led to a dramatic rise in women's physical and mental health issues. While digital health solutions, now under the broader term of virt...
Cigna International survey finds perception of safety and acceptance of COVID-19 vaccines improving
2021-06-02 11:36
12638
Key research findings: * Vaccine rollout progressing well - 25% of our sample of over 13,000 people are now vaccinated * Overall vaccine acceptance up from 63% to 66%, and 60% of people believe vaccines will be readily available to them, up 2% * Notable differences between markets, particul...
Daewoong Pharmaceutical Publishes Results of First Clinical Study of SGLT-2 Inhibitor 'Enavogliflozin' for Canine Diabetes
2021-06-01 21:00
1447
SEOUL, South Korea, June 1, 2021 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Sengho Jeon) announced that the results of an investigator-initiated clinical study on the effect of Enavogliflozin, originally developed as Type II Diabetes Treatment forhumans, on treating canine diabetes were publish...
Medical Informatics Corp. Commended by Frost & Sullivan for Setting a New Standard of Care through its SaaS-based Solution, Sickbay™
2021-06-01 20:00
1321
Sickbay's™ technology allows hospitals to enable rapid data collection from diverse medical devices ensuring clinical staff have access to near real-time bedside data to support remote monitoring and patient centered analytics at scale SANTA CLARA, Calif., June 1, 2021 /PRNewswire/ -- Based on i...
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain
2021-06-01 17:30
1359
MELBOURNE, Australia, June 1, 2021 /PRNewswire/ -- Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product...
Intellicare partners with UnionBank to open fully digital ePaycard accounts for affiliated doctors
2021-06-01 14:19
2379
SINGAPORE, June 1, 2021 /PRNewswire/ -- Asalus Corporation (operating under the trade name "Intellicare"), one of the country's leading health maintenance organization (HMO), recently partnered with Union Bank ofthe Philippines (UnionBank), renowned as the "best digital bank" in the country, for ...
Singapore-based Impact Investor Heritas Capital Announces US$60M First Close of Heritas Growth Fund III to Back Asian Emerging Champions Driving Sustainable Covid-19 Recovery
2021-06-01 09:00
1971
* Pan-Asia Impact Fund to back high-growth emerging champions developing smart platforms that enhance access to affordable quality healthcare and education for sustainable post-Covid recovery, in line with UN Sustainable Development Goals (SDGs) * Builds on successful track record of earlier ...
Introduce the World's First Biomedical Application Mask that Revolutionizes Face Mask to Resist Aerosol Transmission
2021-05-31 23:00
1588
TAIPEI, May 31, 2021 /PRNewswire/ -- Taer Innovation has won design awards including Good Design award from 2012 to 2014 Golden Pin Design award, Taiwan Excellence award in 2014 and Computex d&I award in 2014 for their products.The companyfocuses on medical innovation and technology. The company'...
RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021
2021-05-31 19:33
1573
STOCKHOLM, May 31, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,May 31, 2021, that it confirms its previous forecast to be able to conclude recruitment for its multi-centre BRaVac Phase IIb study in Quarter 3 2021. Also, all new US clinics hav...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 289 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 288 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 284 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 280 media titles]
2024-04-18 14:00Most Read
Animated Life in Yunnan
2024-04-18 14:00
7169
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
6947
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
5263
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3596